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Abstract Synaptojanin 1 is an inositol 5-phosphatase with a 
putative role in clathrin-mediated endocytosis. Goal of this study 
was to provide new evidence for this hypothesis. We show that 
synaptojanin 1 is concentrated at clathrin-coated endocytic 
intermediates in nerve terminals. Furthermore, we report that 
synaptojanin-170, an alternatively spliced isoform of synaptoja-
nin 1, binds Epsl5, a clathrin coat-associated protein. Binding is 
mediated by the COOH-terminal region of synaptojanin-170 
which we show here to be poorly conserved from rat to humans, 
but to contain in both species three asparagine-proline-phenyl-
alanine (NPF) repeats. This motif has been found to be the core 
of the binding site for the EH domains of Epsl5. Together with 
previous data, our results suggest that synaptojanin 1 can be 
recruited to clathrin-coated pits via a multiplicity of interactions. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Synaptojanin 1 (formerly referred to as synaptojanin, [1]) 
was originally identified as one of the major Grb2-binding 
proteins in synaptic membranes [2]. Immunofluorescence as 
well as biochemical evidence suggests that it participates in 
synaptic vesicle endocytosis at a step closely related to dyna-
min's site of action [3]. Cloning of rat synaptojanin 1 revealed 
a NH2-terminal domain homologous to the cytoplasmic por-
tion of the yeast protein Saclp, a central inositol 5-phospha-
tase domain and a COOH-terminal proline-rich region [4]. 
This proline-rich region mediates the binding of synaptojanin 
1 to a variety of SH3 domain-containing proteins including 
amphiphysin [5,6], SH3p4, SH3p8, SH3pl3 [7,8] and Grb2 [2]. 
Synaptojanin 2, a recently identified synaptojanin homolog, is 
very similar to synaptojanin 1 in the Sacl homology and in-
ositol 5-phosphatase domains, but differs substantially in the 
proline-rich region. Accordingly, synaptojanin 1 and 2 have 
different interaction partners and are likely to have different 
biological functions [1]. 
Two synaptojanin 1 isoforms of 145 kDa (synaptojanin-
145) and 170 kDa (synaptojanin-170) are generated by an 
alternative splicing mechanism [9]. Synaptojanin-170 differs 
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from synaptojanin-145 by a 30 kDa extension of its proline-
rich COOH-terminal domain. Both synaptojanin-145 and syn-
aptojanin-170 are expressed at low concentrations in a variety 
of tissues [9], but synaptojanin-145 is very abundant in nerve 
terminals, consistent with the hypothesis that it may play a 
key role in the clathrin-mediated endocytosis of synaptic 
vesicles [4,10]. 
A protein that has recently been implicated in clathrin-
mediated endocytosis is Epsl5, a ubiquitously expressed 150 
kDa protein first identified as a major substrate for the tyro-
sine kinase activity of the EGF receptor [11]. Several lines of 
evidence strongly suggest the involvement of Epsl5 in the 
generation of clathrin-coated vesicles from the plasma mem-
brane. First, Epsl5 was shown to bind to the ot-subunit (ot-
adaptin) of the clathrin adaptor protein AP2 [12,13]. Second, 
an electron microscopy immunocytochemical study demon-
strated a concentration of Epsl5 at the neck of clathrin-
coated pits [14]. Third, the NH2-terminal domain of Espl5 
contains three conserved repeats of about 70 amino acids 
referred to as EH (Epsl5 homology) domains [15]. EH do-
mains are protein-protein interaction modules which are 
present in a variety of proteins including two yeast proteins 
with a putative role in endocytosis and actin function, End3 
[16] and Panl [17]. A recent analysis of the EH domains of 
Epsl5 performed by a phage display library identified the 
amino acid sequence asparagine-proline-phenylalanine (NPF) 
as the core of the EH domain-binding site [18]. Three NPF 
motifs are present in the COOH-terminal region unique to rat 
synaptojanin-170, suggesting that this protein is a potential 
binding partner for Epsl5. 
In this paper we show the localization of synaptojanin 1 at 
clathrin-coated endocytic intermediates and demonstrate an 
interaction between synaptojanin-170 and Epsl5 providing 
further evidence for the role of synaptojanin 1 in clathrin-
mediated endocytosis. 
2. Materials and methods 
2.1. Antibodies 
Antibodies against Epsl5 were previously described [18]. Rabbit 
and mouse polyclonal antibodies specific for synaptojanin 1 were 
raised against the proline-rich region of rat synaptojanin-145 using 
a fusion protein comprising amino acids 1156-1286 as the immuno-
gen. A mouse monoclonal antibody (AC1) directed against the same 
region of synaptojanin 1 was raised by standard methods. This anti-
body recognizes human synaptojanm 1 only very weakly. A rabbit 
antibody specific for synaptojanin-170 was previously described [4]. 
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2.2. Immunogold electron microscopy 
Gently homogenized rat retinas or hypotonically lysed brain syn-
aptosomes were incubated in the presence of brain cytosol, ATP and 
GTPyS to enhance formation of coated endocytic intermediates and 
embedded in agarose [19]. Immunogold labeling was performed as 
described using anti-dynamin monoclonal antibodies Hudy-1 (Upstate 
Biotechnology, Lake Placid, NY, USA) and mouse anti-synaptojanin 
1 polyclonal antibodies. 
2.3. Cloning of human synaptojanin 1 
Rat synaptojanin probes were used to isolate from a human cere-
bellar cDNA library (Stratagene) two overlapping clones encompass-
ing the complete coding region of human synaptojanin 1, including 
the stop codon at position 1311 and the second open reading frame 
[4]. A full-length clone was constructed and sequenced on both 
strands. The presence of an alternatively spliced human synaptojanin 
1 mRNA encoding synaptojanin-170 was demonstrated by amplifying 
the region around the stop codon at amino acid 1311 from human 
peripheral lymphocyte cDNA using the primers 5'-CGGCG-
GAATTCGGGCATCTGCTGGAAGACTGACT-3' and 5'-CGGC-
GTCTAGAAGCTGGAATTGGAGGCATTGTTG-3'. 
2.4. Recombinant proteins 
The NH2-terminal region of Epsl5 (amino acids 2-330) including 
the three EH domains was expressed as a GST fusion protein (GST-
EH) and purified on GST-sepharose [18]. The COOH-terminal region 
unique to rat synaptojanin-170 (amino acids 1309-1576) (SJ170C) 
containing the three NPF motifs was amplified using the primers 5'-
AAACCGGAATTCCAGCAGGTAAAAATAAATGG-3' and 5'-
AAACGCATCGACTCTTTCTGTGAAGTCCAATG-3', subcloned 
into pGEX (Pharmacia), sequenced and expressed as a GST fusion 
protein. SJ170C subcloned into pCDNA3.1 (Invitrogen) was transi-
ently expressed in CHO cells using the lipofection method (Gibco 
BRL). 
Fig. 1. Localization of synaptojanin in nerve terminal membranes revealed by immunogold electron microscopy. Gently homogenized rat retinas 
(a, b, d, e) or hypotonically lysed brain synaptosomes (c and f) were incubated in the presence of brain cytosol, ATP and GTPyS to enhance 
formation of coated endocytic intermediates, embedded in agarose and labeled by immunogold as described [19]. Note in (a) the concentration 
of anti-synaptojanin immunogold on matrix material interspersed among synaptic vesicles. The inset in (a) shows at a higher magnification an 
area of the main field demonstrating the presence of a clathrin-like lattice in correspondence to a cluster of immunogold. Arrowheads in (b) 
and (c) point to a labeled and an unlabeled clathrm-coated profile respectively. Arrows in (c) indicate grazing sections through tangentially cut 
clathrin coats. A complex membrane invagination ending in multiple clathrin-coated buds is visible in (d) and is heavily labeled by immuno-
gold. Dynamin-coated tubules decorated by scattered anti-synaptojanin immunogold are visible in (b) and (e). The labeling was performed by 
mouse anti-synaptojanin polyclonal antibodies and anti-dynamin monoclonal antibodies Hudy-1 (Upstate Biotechnology, Lake Placid, NY, 
USA) folowed by rabbit anti-mouse IgGs and protein A gold. The same type of tubules are heavily and homogeneously decorated by anti-dy-
namin immunogold (f). Bar: a = 250 nm (inset 500 nm); b-f=200 nm. 
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2.5. Affinity chromatography 
Triton X-100 extracts of 19 days embryonic rat brain were prepared 
as described [9], incubated for 4 h with GST-EH or GST-SJ170C 
prebound to glutathione sepharose, and eluted with SDS sample buff-
er. Triton X-100 extracts of SJ170-expressing CHO cells were pre-
pared as described [3] and either incubated with GST-EH or separated 
by SDS-PAGE for overlay experiments. 
2.6. Miscellaneous procedures 
Overlay assays, SDS-PAGE and Western blotting were performed 
as described [5]. 
3. Results 
Immunofluorescence and subcellular fractionation data 
have demonstrated a concentration of synaptojanin 1 in nerve 
terminals [3]. However, its distribution was not investigated so 
far by electron microscopy. To determine the subcellular lo-
calization of synaptojanin 1 at the ultrastructural level, nerve 
terminal membranes from rat brain and retinas (synaptojanin 
1 is highly concentrated in retinal synapses) were incubated 
with rat brain cytosol, ATP and GTP7S, i.e. under conditions 
which greatly enhance the formation of coated endocytic in-
termediates [19]. After fixation, these membranes were labeled 
by immunogold for synaptojanin 1 (using an antibody that 
recognizes both synaptojanin 1 isoforms) and for dynamin as 
a control. Fig. la shows that in nerve terminals synaptojanin 
1 immunoreactivity is concentrated at 'hot spots' interspersed 
among the synaptic vesicles. The vesicles themselves were not 
labeled in agreement with previous subcellular fractionation 
data [3]. The 'hot spots' generally corresponded to matrix 
material and often included portions of clathrin coats recog-
nizable by their characteristic icosahedral morphology (Fig. 
la-c). Complex membrane invaginations ending in multiple 
clathrin-coated buds were often visible in retinal synapses, 
and synaptojanin 1 was highly concentrated around their 
coats (Fig. Id). Synaptojanin 1 immunolabeling, however, 
was not homogeneous on clathrin coats (Fig. Id), and some 
TAA 
Fig. 2. Comparison between the amino acid sequences of rat [4] and human (accession numbers AF009039 and AF009040) synaptojanin. A: 
Alignment of the two sequences (non-identical amino acid residues are highlighted). The sequence enclosed by a discontinuous line around the 
stop codon at position 1311 of human synaptojanin (asterisk) corresponds to an exon which is omitted in the mRNA encoding synaptojanin-
170, but included in the mRNA encoding synaptojanin-145. This alternative splicing mechanism generates the 170 and the 145 kDa isoform 
respectively. The three NPF motifs in the COOH-terminal region of synaptojanin-170 are outlined. B: Domain cartoon of synaptojanin and 
percent identity between the human and rat protein for each of the domains. 
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Fig. 3. Interaction between Epsl5 and synaptojanin-170. A: Affinity purification of a Triton X-100 extract of 19 days embryonic rat brain on 
GST fusion proteins of either Grb2 or the NH2-terminal region of human Epsl5 (amino acids 2-330) which comprises its three EH domains 
(GST-EH) [18]. The figure shows Western blots probed with an antibody directed against the proline-rich region of synaptojanin-145 (lanes a-
c) or against the C-terminal region specific to synaptojanin-170 (lanes d and e). SM, starting material (detergent extract); lanes b-e, material 
bound to the GST proteins immobilized on glutathione-agarose beads. B: Affinity purification of a detergent extract of adult rat brain on a 
GST fusion protein consisting of the COOH-terminal region of rat synaptojanin-170 (SJ170C) (amino acids 1309-1576). The starting material 
(lane a) and the material bound to the fusion protein or to GST alone (lanes b and c) were detected by Western blotting with antibodies di-
rected against Epsl5. C: Affinity purification on GST-EH of a detergent extract of CHO cells expressing the COOH-terminal region of synap-
tojanin-170 (SJ170C). The starting material (a) and the material bound to GST-EH or to GST alone (lanes b and c) were probed by Western 
blotting with antibodies directed against SJ170C. D: SDS gels of total homogenates of untransfected CHO cells (lane c) and CHO cells trans-
fected with SJ170C (lanes a and b) were probed with either antibodies directed against SJ170C (lane a) or the GST-EH fusion protein followed 
by anti-GST antibodies (lanes b and c). The GST-EH fusion protein binds to several bands (see also [15]), but only in transfected cells does it 
detect a protein band with the same motility as SJ170C. 
clathrin-coated membrane profiles were completely unlabeled 
(Fig. lc), indicating that synaptojanin 1 is not an intrinsic 
component of the coat. Similar results were previously ob-
tained for amphiphysin [20] and dynamin [21]. Clusters of 
synaptojanin 1 immunogold were also present on the dyna-
min-coated tubules which form in the presence of GTPyS, but 
the uneven localization of anti-synaptojanin 1 immunogold on 
these structures (Fig. lb,e) clearly differed from the heavy, 
continuous labeling produced by anti-dynamin immunogold 
(Fig. If). These data further support an involvement of syn-
aptojanin 1 in clathrin-mediated endocytosis. 
Targeting of both synaptojanin 1 isoforms to clathrin-
coated membrane areas may be mediated by SH3 domain-
containing proteins, including amphiphysin [5], as previously 
shown for dynamin [22,23]. Amphiphysin binds to synaptoja-
nin 1 and dynamin 1 via its SH3 domain [5,24], whereas a 
different domain is responsible for its binding to clathrin 
[6,25] and to the appendage domain of the oc-subunit (oe-adap-
tin) of the clathrin adaptor AP2 [5,26]. The possibility of an 
alternative targeting mechanism selective for synaptojanin-170 
was raised by the recent discovery of NPF motifs as the core 
sequence of ligands for the EH domains of Epsl5 [18]. Via a 
distinct domain Epsl5, like amphiphysin, binds a-adaptin 
[12,13]. Three NPF motifs are present in the COOH-terminal 
domain of synaptojanin-170. We have now cloned both iso-
forms of human synaptojanin 1 and found that the alternative 
splicing mechanism generating these isoforms is conserved 
(Fig. 2). Rat and human synaptojanin 1 have highly conserved 
Sacl homology and inositol 5-phosphatase domains but differ 
substantially in their COOH-terminal proline-rich tails. How-
ever, the three NPF motifs in the COOH-terminal domain 
unique to synaptojanin-170 are conserved, indicating their 
functional importance. 
To investigate whether synaptojanin-170 and Epsl5 can in-
teract, a GST fusion protein of the NH2-terminal domain of 
Epsl5, containing its three EH domains (GST-EH) [18], was 
used to affinity purify a non-ionic detergent extract of embry-
onic brain, which is enriched in synaptojanin-170 [4]. As 
shown in Fig. 3A, synaptojanin-170 was present in the start-
ing material only at the limit of detectability under the West-
ern blotting conditions used, but was highly enriched in the 
eluate of the GST-EH affinity column. A Grb2 affinity column 
retained both synaptojanin isoforms as previously described 
[2] (Fig. 3A). Conversely, Epsl5 present in an adult rat brain 
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extract was selectively affinity purified by a GST fusion pro-
tein comprising the COOH-terminal region of rat synaptoja-
nin-170 (SJ170C) (Fig. 3B). 
To further confirm that this interaction is mediated by the 
NPF-containing region of synaptojanin-170, the COOH-ter-
minal fragment unique to synaptojanin-170 was expressed in 
CHO cells and detergent extracts of the cells were affinity 
purified on the GST-EH affinity column. As shown by Fig. 
3C, the synaptojanin 1 fragment was specifically retained by 
the column. Finally, the COOH-terminal fragment of synap-
tojanin-170 expressed in CHO cells was recognized by the 
GST-EH fusion protein in a gel overlay assay (Fig. 3D), 
thus demonstrating that the interaction is direct. 
4. Discussion 
The results reported in this study provide new evidence 
supporting a role of synaptojanin 1 in endocytosis. We have 
shown that in nerve terminal membranes synaptojanin 1 is 
concentrated on endocytic intermediates. Its localization on 
clathrin-coated membrane invaginations was similar to that 
of amphiphysin 1 [20] and dynamin ([21] and this study). 
On dynamin-coated tubules, synaptojanin 1 had a scattered 
distribution similar to that of amphiphysin 1 [20]. These data 
strongly support the hypothesis that the functions of dynamin 
and synaptojanin 1 are closely interrelated and that amphi-
physin is a physiological binding partner for both proteins 
[10]. Synaptojanin 1 was also recruited to clathrin- and dyna-
min-coated intermediates when brain cytosol was incubated 
with fibroblastic membranes (our unpublished observations). 
Although our anti-synaptojanin 1 antibodies did not produce 
a detectable fluorescent signal outside the nervous system 
(probably due to the much lower concentration of synaptoja-
nin 1 in non-neuronal tissue), synaptojanin 1 may play a 
conserved function in nerve terminals and non-neuronal cells. 
This possibility is supported by the biochemical detectability 
of both isoforms of synaptojanin 1 in a variety of tissues and 
by the presence of synaptojanin homologs in S. cerevisae [27]. 
Additional evidence for an involvement of synaptojanin 1 in 
endocytosis comes from the identification of its 170 kDa iso-
form as an Epsl5-binding protein. Epsl5, first discovered as a 
component of the EGF receptor signal transduction machin-
ery [11], is now recognized as an important protein of endo-
cytic clathrin coats [12-15]. Binding of the EH domain-con-
taining region of Epsl5 to the NPF-containing region of 
synaptojanin 1 could be demonstrated by a variety of in vitro 
assays, although not by in vivo coprecipitation. The physio-
logical significance of these findings, however, is supported by 
independent work carried out in yeast showing genetic inter-
action between the Panl protein (which contains two EH 
domains) and the Sjll protein [27], a yeast homolog of syn-
aptojanin 1 which contains one NPF motif (B. Wendland and 
5. Emr, personal communication). The interaction between 
Epsl5 and synaptojanin-170 may be very transient, or subject 
to regulation, and therefore difficult to detect in vivo. 
Epsl5 is present in nerve terminals (our unpublished obser-
vations). However, adult brain predominantly expresses syn-
aptojanin-145 [4]. Thus, the direct binding of Epsl5 to syn-
aptojanin-170 does not appear to be critical for the specialized 
clathrin-mediated endocytosis of synaptic vesicles character-
istic of synapses. Synaptojanin-170, which is relatively more 
enriched than synaptojanin-145 in developing brain as well as 
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in non-neuronal cells [4,9], may instead be implicated in a 
house-keeping mechanism of endocytosis conserved from 
yeast to mammalian cells and possibly in additional functions. 
A similar situation may exist with proteins of the API80 fam-
ily, which are also thought to participate in the endocytic 
reaction [28-30]. The API80 family member concentrated at 
synapses does not contain NPF motifs [28]. However, its 
house-keeping homologue CALM [31], as well as its two ho-
mologues in S. cerevisae, have multiple NPF motifs. Accord-
ingly, genetic and biochemical interactions between Panl and 
API80 homologues have also been observed in yeast (B. 
Wendland and S. Emr, personal communication). 
Epsl5 is associated with, and is phosphorylated by, the 
EGF receptor kinase upon EGF stimulation [11]. It is note-
worthy that in transfected cells synaptojanin-145 has been 
shown to bind the activated EGF receptor, most likely via 
the adaptor protein Grb2 [32]. Thus, both isoforms of synap-
tojanin 1 may be involved in protein interaction cascades 
downstream of tyrosine receptor kinase signaling. Effects of 
the inositol 5-phosphatase activity of synaptojanin 1 on intra-
cellular signaling may overlap with effects of this activity on 
endocytosis and actin function mediated by a modification of 
the phosphoinositide composition of the membrane [33]. In 
conclusion these findings represent yet another example of 
the important interconnections which are emerging between 
molecular mechanisms implicated in the endocytic reaction of 
clathrin-coated vesicles and signaling cascades activated by 
receptors which are internalized by clathrin-mediated endocy-
tosis [34]. 
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